bioept (BIOC)表示,它允许Plus (PSTV)在其临床试验和商业中使用CNSide测试,等待监管部门的批准。Plus Therapeutics (PSTV)的股票在反...查看全文
不入流资讯2023-09-08 20:23
$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy查看全文
牛股小红书2022-04-06 13:10
$Plus Therapeutics(PSTV)$ 表示,已扩大与Dassault Systèmes(OTCPK:DASTY)旗下公司Medidata的合作伙伴关系,以加快Rhenium-186纳米脂质体治疗复发性胶质母细胞瘤的2期临床试验的注册速度,降低临床试验成本。
该合作关系将使用Medidata的合成控制臂平台,该平台以美国食品和药物管理局认可...查看全文
薛定锷之猫2021-11-23 09:49
$Plus Therapeutics(PSTV)$ 所谓的放射性纳米疗法治复发性GBM,大概率失败?终于明白当初TOCA为啥也是找晚期复发性GBM下手了。市值2千万,真正的仙股啊。查看全文
$Plus Therapeutics(PSTV)$ 8-K Current report, item 7.01 Accession Number: 0000950170-23-007414 Act: 34 Size: 165 KB 网页链接
$Plus Therapeutics(PSTV)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-23-063024 Act: 34 Size: 1 MB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-016526 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, and 9.01 Accession Number: 0001193125-23-060090 Act: 34 Size: 217 KB 网页链接
$Plus Therapeutics(PSTV)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-23-048931 Act: 34 Size: 1 MB 网页链接
$Plus Therapeutics(PSTV)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-004099 Act: 34 Size: 9 MB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-004104 Act: 34 Size: 638 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-010652 Size: 5 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-010636 Size: 5 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-010637 Size: 5 KB 网页链接